Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy

Published:2018-01 Issue: Volume:97 Page:225-232
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Acheampong Desmond O.,Adokoh Christian K.,Asante Du-Bois,Asiamah Ernest A.,Barnie Prince A.,Bonsu Dan O.M.,Kyei Foster

Funder

Antibody Engineering Laboratory, School of Life Science Technology, China Pharmaceutical University, Nanjing, China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference106 articles.

1. Ito K: DNMT3A and TET2 in the pre-leukemic phase of hematopoietic disorders;Sato;Front. Oncol.,2016

2. Acute myeloid leukemia—major progress over four decades and glimpses into the future;Kantarjian;Am. J. Hematol.,2016

3. Acute myeloid leukemia: a retrospective claims analysis of resource utilization and expenditures for newly diagnosed patients from first-line induction to remission and relapse;Irish;Curr. Med. Res. Opin.,2017

4. Cancer statistics, 2015;Siegel;CA. Cancer J. Clin.,2015

5. Childhood and adolescent cancer statistics, 2014;Ward;CA. Cancer J. Clin.,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis and treatment in acute myeloid leukemia: a comprehensive review;Egyptian Journal of Medical Human Genetics;2024-08-06

2. The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies;Cancers;2024-07-23

3. A glycosylation-related signature can predict prognosis and immunotherapy response in patients with acute myeloid leukaemia;2024-06-18

4. Nanozymes: a new approach for leukemia therapy;Journal of Materials Chemistry B;2024

5. MALAT-1 regulates the AML progression by promoting the m6A modification of ZEB1;Acta Biochimica Polonica;2023-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3